The US Food and Drug Administration (FDA)’s warning to a Florida-based manufacturer over illegal flavoured nicotine gummies has been welcomed by public health organisations, while it has not gone down well with some representatives of the vaping industry.

The non-profit Campaign for Tobacco-Free Kids welcomed the action against Krave gummies, which it says “pose serious risks to kids”. Leading the opposition to the FDA action was Charles Gardner, executive director of the International Network of Nicotine Consumer Organisations (INNCO), who described nicotine gummies as a niche product and said that by focusing on nicotine, the agency was missing greater dangers.

 

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation